Patents by Inventor Ivan Udovicic

Ivan Udovicic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6288028
    Abstract: The present invention discloses new pharmaceutical compositions useful for the treatment of various human and animal diseases. These pharmaceutical compositions contain one or more peptides.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: September 11, 2001
    Inventors: Predrag Sikiric, Marijan Petek, Sven Seiwerth, Branko Turkovic, Zeljko Grabarevic, Ivo Rotkvic, Stjepan Mise, Marko Duvnjak, Ivan Udovicic
  • Patent number: 6268346
    Abstract: Peptides having 8 to 15 amine acid residues and a molecular weight between 900 and 1600 Daltons. The peptides have a biological activity comparable to the protein BPC.
    Type: Grant
    Filed: December 2, 1998
    Date of Patent: July 31, 2001
    Inventors: Predrag Sikiric, Marijan Petek, Sven Seiwerth, Zelijko Grabarevic, Ivo Rotkvic, Marko Duvnjak, Branko Turkovic, Stiepan Mise, Ernest Suchanek, Boris Mildner, Ivan Udovicic
  • Patent number: 6211151
    Abstract: Peptides having 8 to 15 amino acid residues and a molecular weight between 900 and 1600 Daltons. The peptides have a biological activity comparable to the protein BPC.
    Type: Grant
    Filed: August 23, 1994
    Date of Patent: April 3, 2001
    Inventors: Predrag Sikiric, Marijan Petek, Sven Seiwerth, Zelijko Grabarevic, Ivo Rotkvic, Marko Duvnjak, Branko Turkovic, Stiepan Mise, Ernest Suchanek, Boris Mildner, Ivan Udovicic
  • Patent number: 5288708
    Abstract: A new substance BPC; the process for its preparation from human and animal gastric juice comprising purifications steps: centrifugalization, dialysis, ion-exchange, chromotagraphy, gal chromatography and lyophilisation; a drug for human and veterinary use and a process for the treatment of stress-induced diseases and disorders, inflammation and edemas, diseases and disorders of dopaminergic etiology, for treatment of diabetes mellitus, diseases and disorders of gastrointestinal tract, heart, kidney, pancreas, liver, testis, hematopoetic, skeletal and nervous, system, dementias, wound, burns, fracture, viral diseases, malignancy; in surgery; some disorders of fertility and immune system; protection against ionizing radiation; for veterinary use in commercial breeding.
    Type: Grant
    Filed: May 10, 1991
    Date of Patent: February 22, 1994
    Inventors: Predrag Sikiric, Marijan Petek, Ivo Rotkvic, Stjepan Mise, Simun Krizanac, Ivan Udovicic, Ernest Suchanek, Marko Duvnjak, Jerka Jukic
  • Patent number: 5252481
    Abstract: A mutant of bacterium Clostridium histolyticum, designated Clostridum histolyticum K26 clo 88 of the following characteristics: the lack of a motility system which is a fundamental characteristic of the parenteral strain; and, the inability to biosynthesize the accompanying enzyme clostripain. A process of obtaining the above mutant and its use in a process for the production of clostripain-free collagenase are also provided.
    Type: Grant
    Filed: July 23, 1991
    Date of Patent: October 12, 1993
    Assignee: Pliva Farmaceutska, Kemijska
    Inventors: Milan Holjevac, Ivan Udovicic, Sonja Cizmek, Vlasta Sojak-Derkos, Stjepan Gamulin, Vladimir Delic